http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2649572-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d584042a524740a406723fe1631e49e5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-42
filingDate 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71324abce8c30c78cae3f328ec81dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8be527e419ad00c3e090f6f91af08c12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f6f688e121a57296ae6eb07a458bd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_252bb500912788f37e8d6b2c54d25bde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade87d70b6c0baf3330f835b3adf3c9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38f036e76c4d649a9a6b88254c307744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e68095272d5c1a1691b13e1cd55b1dd
publicationDate 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2649572-C1
titleOfInvention Method of treatment of patients with acute myocardial infarction with massive thrombosis of the infarct-related coronary artery
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to cardiology. Emergency coronary angiography is performed, and when an acute occlusion of the coronary artery is detected and a thrombus length of more than 3 artery diameters is present, antiplatelet therapy comprising itegrylin with heparin or bivalirudin is performed. Then, after 1 day, control angiography is performed and stenting of hemodynamically significant residual stenosis is performed. In special case, when an absence of TIMI-2-3 blood flow in an infarct-related coronary artery is detected on an emergency coronary angiography, a partial destruction of the thrombus by a conductor with an undisclosed coronary balloon is performed, restore the blood flow to TIMI-2-3. n EFFECT: method allows to shorten the term of the patient in the intensive care unit and the general period of hospitalization, to prevent the phenomenon of no-reflow. n 1 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745651-C1
priorityDate 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2483750-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503083

Total number of triples: 39.